Items Tagged ‘pembrolizumab’

November 13, 2019

UCLA Health continues to transform cancer care

By uclahealth uclahealth

In the late 1960s, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education and patient care. Today, UCLA Health’s Jonsson Comprehensive Cancer Center (JCCC) has established an international reputation for providing the best in leading-edge and traditional cancer treatments […]

View full entry

Tags: advanced lung cancer, breast cancer, CAR T cell therapy, Dr. Antoni Ribas, Dr. Arie Bellgedrun, Dr. Dennis Slamon, Dr. Edward Garon, Dr. Richard Finn, Dr. Sara Hurvitz, HER2-positive, HER2+, Herceptin


Pembrolizumab (Keytruda®) Offers New Hope for Patients with Metastatic Melanoma

June 7, 2016

Pembrolizumab (Keytruda®) Offers New Hope for Patients with Metastatic Melanoma

By uclahealth uclahealth

In the summer of 2015, a brand-new cancer therapy known as “Jimmy Carter’s cancer drug” shot to fame. Called pembrolizumab, it was instrumental in former President Jimmy Carter’s successful treatment for metastatic melanoma. Previously, patients with metastatic melanoma (skin cancer that has spread to other areas of the body) could undergo a combination of treatment […]

View full entry

Tags: cancer drug, chemotherapy, immune system, immunotherapy, keytruda, melanoma, metastatic melanoma, pembrolizumab, radiation therapy, skin cancer, skin diseases, surgery